Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere with Most ABO Typings.

Yazer MH, Spinella PC, Doyle L, Kaufman RM, Dunn R, Hess JR, Filho LA, Fontaine M, Gathof B, Jackson B, Murphy MF, Pasion J, Raval JS, Rosinski K, Seheult J, Shih AW, Sperry J, Staves J, Tuott EE, Ziman A, Triulzi DJ, McKenna D, Stroncek D, Fung M, Tinmouth A, Devine D, Cardigan R, Vassallo R, Germain M, Reems J, Garritsen H, Takanashi M, Stanworth S, Delaney M, Cancelas J, Meer PV, Marks D, Cohn C, Shaz B, Tiberghien P, Goldman M, Girdlestone J, Pati S, Schäfer R, Schwartz JY, Dunbar N, Pagano M, So-Osman C, Noorman F, Apelseth TO, Kanias T, Stolla M, Angelantonio ED, Hurk KVD, Steele WR, Erikstrup C, Merz EM; Biomedical Excellence for Safer Transfusion Collaborative; Appendix. Members of the Biomedical Excellence for Safer Transfusion Collaborative.

Anesthesiology. 2019 Nov 25. doi: 10.1097/ALN.0000000000003069. [Epub ahead of print]

PMID:
31789634
2.

Persisting higher prevalence of hepatitis A virus RNA in blood donors, France, 2018.

Gallian P, Barlet V, Mouna L, Gross S, Morel P, Le Cam S, Ricard C, Maugard C, Pouchol E, Flan B, Visse C, Djoudi R, Figoni J, De Valk H, Tiberghien P, Roque-Afonso AM.

Euro Surveill. 2019 Nov;24(47). doi: 10.2807/1560-7917.ES.2019.24.47.1900695. No abstract available.

3.

The systematic use of evidence-based methodologies and technologies enhances shared decision-making in the 2018 International Consensus Conference on Patient Blood Management.

Van Remoortel H, Aranko K, Mueller MM, De Buck E, Devine D, Folléa G, Meybohm P, Tiberghien P, Wood EM, Vandekerckhove P, Seifried E.

Vox Sang. 2020 Jan;115(1):60-71. doi: 10.1111/vox.12852. Epub 2019 Nov 10.

PMID:
31709562
4.

Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patients.

Martinaud C, Tiberghien P, Bégué S, Sailliol A, Gross S, Pouget T, Ausset S.

Transfus Clin Biol. 2019 Nov;26(4):198-201. doi: 10.1016/j.tracli.2019.09.004. Epub 2019 Oct 1.

PMID:
31645305
5.

Transfusion-Transmitted Hepatitis E Virus Infection in France.

Gallian P, Pouchol E, Djoudi R, Lhomme S, Mouna L, Gross S, Bierling P, Assal A, Kamar N, Mallet V, Roque-Afonso AM, Izopet J, Tiberghien P.

Transfus Med Rev. 2019 Jul;33(3):146-153. doi: 10.1016/j.tmrv.2019.06.001. Epub 2019 Jun 20. Review.

PMID:
31327668
6.

The best blood product and its best use for each patient: An evolving role for hemovigilance?

Tiberghien P.

Transfus Clin Biol. 2019 Sep;26(3):188-191. doi: 10.1016/j.tracli.2019.04.001. Epub 2019 May 15.

PMID:
31178340
7.

Viral load and clinical manifestations of hepatitis E virus genotype 3 infections.

Lhomme S, Gallian P, Dimeglio C, Assal A, Abravanel F, Tiberghien P, Izopet J.

J Viral Hepat. 2019 Sep;26(9):1139-1142. doi: 10.1111/jvh.13128. Epub 2019 Jun 10.

PMID:
31099059
8.

Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference.

Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, Carson JL, Cichutek K, De Buck E, Devine D, Fergusson D, Folléa G, French C, Frey KP, Gammon R, Levy JH, Murphy MF, Ozier Y, Pavenski K, So-Osman C, Tiberghien P, Volmink J, Waters JH, Wood EM, Seifried E; ICC PBM Frankfurt 2018 Group.

JAMA. 2019 Mar 12;321(10):983-997. doi: 10.1001/jama.2019.0554.

PMID:
30860564
9.

Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing.

Cappy P, Barlet V, Lucas Q, Tinard X, Pillonel J, Gross S, Tiberghien P, Laperche S.

Transfusion. 2019 Jun;59(6):2046-2053. doi: 10.1111/trf.15203. Epub 2019 Feb 19.

PMID:
30784073
10.

International haemovigilance: what have we learned and what do we need to do next?

Wood EM, Ang AL, Bisht A, Bolton-Maggs PH, Bokhorst AG, Flesland O, Land K, Wiersum-Osselton JC, Schipperus MR, Tiberghien P, Whitaker BI.

Transfus Med. 2019 Aug;29(4):221-230. doi: 10.1111/tme.12582. Epub 2019 Feb 6. Review.

PMID:
30729612
11.

Maternal HLA-G*01:01:01:04 protects from anti-HLA-class II immunization in pregnant women.

Slimane M, Picard C, Chiaroni J, Loundou A, Paganini J, Tiberghien P, Rebibou JM, Di Cristofaro J.

Hum Immunol. 2019 Feb;80(2):120-125. doi: 10.1016/j.humimm.2018.11.003. Epub 2018 Nov 7.

PMID:
30414459
12.

Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017.

Gallian P, Barlet V, Mouna L, Gross S, Lecam S, Ricard C, Wind F, Pouchol E, Fabra C, Flan B, Visse C, Djoudi R, Couturier E, de Valk H, Tiberghien P, Roque-Afonso AM.

Euro Surveill. 2018 May;23(21). doi: 10.2807/1560-7917.ES.2018.23.21.1800237.

13.

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.

Adotevi O, Godet Y, Galaine J, Lakkis Z, Idirene I, Certoux JM, Jary M, Loyon R, Laheurte C, Kim S, Dormoy A, Pouthier F, Barisien C, Fein F, Tiberghien P, Pivot X, Valmary-Degano S, Ferrand C, Morel P, Delabrousse E, Borg C.

Oncoimmunology. 2018 Mar 19;7(5):e1424673. doi: 10.1080/2162402X.2018.1424673. eCollection 2018.

14.

Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.

Garban F, Guyard A, Labussière H, Bulabois CE, Marchand T, Mounier C, Caillot D, Bay JO, Coiteux V, Schmidt-Tanguy A, Le Niger C, Robin C, Ladaique P, Lapusan S, Deconinck E, Rolland C, Foote AM, François A, Jacquot C, Tardivel R, Tiberghien P, Bosson JL; Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP) Study Group.

JAMA Oncol. 2018 Apr 1;4(4):468-475. doi: 10.1001/jamaoncol.2017.5123.

15.

More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.

Tiberghien P, Deconinck E, Adotevi O.

N Engl J Med. 2017 Nov 23;377(21):2101-2. doi: 10.1056/NEJMc1712460. No abstract available.

PMID:
29182255
16.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):e48-e68. doi: 10.1111/vox.12523. Epub 2017 Sep 14. No abstract available.

PMID:
28905396
17.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):680-683. doi: 10.1111/vox.12522. Epub 2017 Sep 14. No abstract available.

PMID:
28905391
18.

Fifteen years of Nucleic Acid Testing in France: Results and lessons.

Laperche S, Tiberghien P, Roche-Longin C, Pillonel J.

Transfus Clin Biol. 2017 Sep;24(3):182-188. doi: 10.1016/j.tracli.2017.06.020. Epub 2017 Jul 11. Review.

PMID:
28709845
19.

Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France.

Duquesnoy A, Danic B, Santos A, Martinaud C, Woimant G, Laperche S, Tiberghien P, Jauffret-Roustide M, Pillonel J; Steering Committee.

Transfusion. 2017 Sep;57(9):2240-2247. doi: 10.1111/trf.14187. Epub 2017 Jul 3.

PMID:
28671313
20.

Changes in France's Deferral of Blood Donation by Men Who Have Sex with Men.

Tiberghien P, Pillonel J, Toujas F, Vallet B.

N Engl J Med. 2017 Apr 13;376(15):1485-1486. doi: 10.1056/NEJMc1700740. No abstract available.

PMID:
28402774
21.

How to quantify microparticles in RBCs? A validated flow cytometry method allows the detection of an increase in microparticles during storage.

Gamonet C, Mourey G, Aupet S, Biichle S, Petitjean R, Vidal C, Pugin A, Naegelen C, Tiberghien P, Morel P, Angelot-Delettre F, Seilles E, Saas P, Bardiaux L, Garnache-Ottou F.

Transfusion. 2017 Mar;57(3):504-516. doi: 10.1111/trf.13989. Epub 2017 Feb 5. Erratum in: Transfusion. 2017 Jun;57(6):1584.

PMID:
28164307
22.

Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors.

Gallian P, Couchouron A, Dupont I, Fabra C, Piquet Y, Djoudi R, Assal A, Tiberghien P.

Transfusion. 2017 Jan;57(1):223-224. doi: 10.1111/trf.13889. No abstract available.

PMID:
28097700
23.

17th International Haemovigilance Seminar: Paris (France), 9-11 March 2016.

Wood E, Bolton-Maggs P, Faber JC, Schipperus KL, Tomasulo P, Wiersum-Osselton J, Boyeldieu D, Cabaud JJ, Cartron JP, Daban JL, Daurat G, Djoudi R, Faurey D, Folléa G, Gouezec H, Garraud O, Laperche S, Lassale B, Lefort C, Muller JY, Oubouzar N, Pirenne F, Py JY, Renaudier P, Roche C, Sailliol A, Tiberghien P, Tinard X.

Blood Transfus. 2016 Mar 2:s1-s80. doi: 10.2450/2016.S1. [Epub ahead of print] No abstract available.

24.

Epidemiology of Chikungunya Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational Study in Volunteer Blood Donors.

Gallian P, Leparc-Goffart I, Richard P, Maire F, Flusin O, Djoudi R, Chiaroni J, Charrel R, Tiberghien P, de Lamballerie X.

PLoS Negl Trop Dis. 2017 Jan 12;11(1):e0005254. doi: 10.1371/journal.pntd.0005254. eCollection 2017 Jan.

25.

Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.

Bougard D, Brandel JP, Bélondrade M, Béringue V, Segarra C, Fleury H, Laplanche JL, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-Wirth C, Knight R, Will R, Tiberghien P, Haïk S, Coste J.

Sci Transl Med. 2016 Dec 21;8(370):370ra182. doi: 10.1126/scitranslmed.aag1257.

PMID:
28003547
26.

Zika virus in asymptomatic blood donors in Martinique.

Gallian P, Cabié A, Richard P, Paturel L, Charrel RN, Pastorino B, Leparc-Goffart I, Tiberghien P, de Lamballerie X.

Blood. 2017 Jan 12;129(2):263-266. doi: 10.1182/blood-2016-09-737981. Epub 2016 Nov 8. No abstract available.

27.

Properties of donated red blood cell components from patients with hereditary hemochromatosis.

Sut C, Hamzeh-Cognasse H, Laradi S, Bost V, Aubrège C, Acquart S, Vignal M, Boutahar N, Arthaud CA, Ange Eyraud M, Pozzetto B, Tiberghien P, Garraud O, Cognasse F.

Transfusion. 2017 Jan;57(1):166-177. doi: 10.1111/trf.13890. Epub 2016 Nov 2.

PMID:
27807848
28.

Case-control study of immediate and delayed vasovagal reactions in blood donors.

Narbey D, Fillet AM, Jbilou S, Tiberghien P, Djoudi R.

Vox Sang. 2016 Oct;111(3):257-265. doi: 10.1111/vox.12418. Epub 2016 May 27.

PMID:
27232998
29.

Prevention of syncopal-type reactions after whole blood donation: a cluster-randomized trial assessing hydration and muscle tension exercise.

Morand C, Coudurier N, Rolland C, Thoret S, Legrand D, Tiberghien P, Bosson JL.

Transfusion. 2016 Oct;56(10):2412-2421. doi: 10.1111/trf.13716. Epub 2016 Jul 24.

PMID:
27453037
30.

Platelet Transfusions in Acute Leukemia.

Tiberghien P, Folléa G, Muller JY.

N Engl J Med. 2016 Jul 7;375(1):96-7. doi: 10.1056/NEJMc1515066. No abstract available.

PMID:
27406370
31.

Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts.

Bôle-Richard E, Gamonet C, Certoux JM, Idirene I, Larosa F, Deconinck E, Mosseley AM, Tiberghien P, Borg C, Ferrand C, Deschamps M.

Gene Ther. 2016 Aug;23(8-9):664-72. doi: 10.1038/gt.2016.39. Epub 2016 May 12.

PMID:
27111151
32.

A nationwide survey of hepatitis E viral infection in French blood donors.

Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, Morel P, Legrand D, Tiberghien P, Izopet J.

Hepatology. 2016 Apr;63(4):1145-54. doi: 10.1002/hep.28436. Epub 2016 Feb 26.

PMID:
27008201
33.

Effect of storage time and donor sex of transfused red blood cells on 1-year survival in patients undergoing cardiac surgery: an observational study.

Desmarets M, Bardiaux L, Benzenine E, Dussaucy A, Binda D, Tiberghien P, Quantin C, Monnet E.

Transfusion. 2016 May;56(5):1213-22. doi: 10.1111/trf.13537. Epub 2016 Mar 2.

PMID:
26935140
34.

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.

van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N; Ebola-Tx Consortium.

N Engl J Med. 2016 Jan 7;374(1):33-42. doi: 10.1056/NEJMoa1511812.

35.

Hepatitis E.

Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, Echevarría JM, Dalton H, Stramer SL.

Vox Sang. 2016 Jan;110(1):93-130. doi: 10.1111/vox.12285. Epub 2015 Jul 21. No abstract available.

PMID:
26198159
36.

[The ABLE study: A randomized controlled trial on the efficacy of fresh red cell units to improve the outcome of transfused critically ill adults].

Lacroix J, Hébert PC, Fergusson D, Tinmouth A, Capellier G, Tiberghien P, Bardiaux L; Canadian Critical Care Trials Group.

Transfus Clin Biol. 2015 Aug;22(3):107-11. doi: 10.1016/j.tracli.2015.04.004. Epub 2015 Jun 3. French.

PMID:
26049675
37.

Age of transfused blood in critically ill adults.

Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, Clayton L, McIntyre L, Callum J, Turgeon AF, Blajchman MA, Walsh TS, Stanworth SJ, Campbell H, Capellier G, Tiberghien P, Bardiaux L, van de Watering L, van der Meer NJ, Sabri E, Vo D; ABLE Investigators; Canadian Critical Care Trials Group.

N Engl J Med. 2015 Apr 9;372(15):1410-8. doi: 10.1056/NEJMoa1500704. Epub 2015 Mar 17.

38.

Transforming growth factor-β released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation.

Vallion R, Bonnefoy F, Daoui A, Vieille L, Tiberghien P, Saas P, Perruche S.

Transfusion. 2015 Jul;55(7):1721-35. doi: 10.1111/trf.13031. Epub 2015 Mar 21.

39.

ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients.

Crepin T, Carron C, Roubiou C, Gaugler B, Gaiffe E, Simula-Faivre D, Ferrand C, Tiberghien P, Chalopin JM, Moulin B, Frimat L, Rieu P, Saas P, Ducloux D, Bamoulid J.

Am J Transplant. 2015 Apr;15(4):1028-38. doi: 10.1111/ajt.13092. Epub 2015 Mar 10.

40.

[Blood transfusion - the value of Research and Development programs].

Garraud O, Morel P, Coste J, Tiberghien P, Fournier-Wirth C.

Presse Med. 2015 Feb;44(2):233-40. doi: 10.1016/j.lpm.2014.06.039. Epub 2015 Jan 8. Review. French.

PMID:
25578552
41.

[Blood transfusion: the challenges for tomorrow?].

Folléa G, Garraud O, Tiberghien P.

Presse Med. 2015 Feb;44(2):227-32. doi: 10.1016/j.lpm.2014.06.038. Epub 2015 Jan 8. Review. French.

PMID:
25578549
42.

Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.

Leboeuf C, Roser-Schilder J, Lambotin M, Durand S, Wu T, Fauvelle C, Su B, Bôle-Richard E, Deschamps M, Ferrand C, Tiberghien P, Pessaux P, Baumert TF, Robinet E.

Gene Ther. 2015 Feb;22(2):172-80. doi: 10.1038/gt.2014.99. Epub 2014 Nov 13.

PMID:
25394253
43.

Hepatitis E virus infections in blood donors, France.

Gallian P, Lhomme S, Piquet Y, Sauné K, Abravanel F, Assal A, Tiberghien P, Izopet J.

Emerg Infect Dis. 2014 Nov;20(11):1914-7. doi: 10.3201/eid2011.140516.

44.

[Research at the Établissement Français du Sang, the French transfusion public service: challenges and responsibilities].

Tiberghien P.

Transfus Clin Biol. 2014 Nov;21(4-5):227-8. doi: 10.1016/j.tracli.2014.08.136. Epub 2014 Sep 27. French. No abstract available.

PMID:
25267202
45.

[Hepatitis E virus: Blood transfusion implications].

Gallian P, Piquet Y, Assal A, Djoudi R, Chiaroni J, Izopet J, Tiberghien P.

Transfus Clin Biol. 2014 Nov;21(4-5):173-7. doi: 10.1016/j.tracli.2014.07.007. Epub 2014 Sep 27. Review. French.

PMID:
25267201
46.

Prospective detection of chikungunya virus in blood donors, Caribbean 2014.

Gallian P, de Lamballerie X, Salez N, Piorkowski G, Richard P, Paturel L, Djoudi R, Leparc-Goffart I, Tiberghien P, Chiaroni J, Charrel RN.

Blood. 2014 Jun 5;123(23):3679-81. doi: 10.1182/blood-2014-03-564880. No abstract available. Erratum in: Blood. 2014 Sep 4;124(10):1695.

PMID:
24904107
47.

Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients.

Ducloux D, Courivaud C, Bamoulid J, Crepin T, Chalopin JM, Tiberghien P, Saas P.

J Am Soc Nephrol. 2014 Jun;25(6):1349-56. doi: 10.1681/ASN.2013060663. Epub 2014 Feb 7.

48.

Hepatitis E transmission by transfusion of Intercept blood system-treated plasma.

Hauser L, Roque-Afonso AM, Beylouné A, Simonet M, Deau Fischer B, Burin des Roziers N, Mallet V, Tiberghien P, Bierling P.

Blood. 2014 Jan 30;123(5):796-7. doi: 10.1182/blood-2013-09-524348. No abstract available.

PMID:
24482503
49.

In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells.

Leboeuf C, Mailly L, Wu T, Bour G, Durand S, Brignon N, Ferrand C, Borg C, Tiberghien P, Thimme R, Pessaux P, Marescaux J, Baumert TF, Robinet E.

Mol Ther. 2014 Mar;22(3):634-644. doi: 10.1038/mt.2013.277. Epub 2013 Dec 6.

50.

Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone.

Gaugler B, Arbez J, Legouill S, Tiberghien P, Moreau P, Derenne S, Saas P, Mohty M.

Cytotherapy. 2013 Jul;15(7):861-8. doi: 10.1016/j.jcyt.2013.03.013.

PMID:
23731764

Supplemental Content

Loading ...
Support Center